Abstract | OBJECTIVE: METHODS: We compared the new Asidan patients and those identified in previous studies with Parkinson's disease (PD, n=21), and progressive supranuclear palsy (PSP, n=13) patients using 123I-2β-Carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane (123I-FP-CIT) dopamine transporter single photon emission computed tomography (DAT-SPECT) and 123I-metaiodobenzylguanidine ( MIBG) myocardial scintigraphy (Asidan, DAT: n=10; MIBG: n=15). RESULTS: Both the PD and PSP groups served as positive controls for DAT decline. The PD and PSP groups served as a positive and negative control, respectively, of MIBG decline in the early phase H/M ratio. Of the Asidan patients, 60.0% showed DAT decline without evident parkinsonian features and 6.7% showed impaired MIBG in only the delayed phase H/M ratio. Combined with a normal range of the early phase H/M ratio, this phenotype was newly named Declined DAT Without Evident Parkinsonism (DWEP). INTERPRETATION: The results of present study including DWEP suggest a wider spectrum of neurodegeneration for extrapyramidal and autonomic systems in Asidan patients than expected, involving cerebellar, motor system and cognitive functioning.
|
Authors | Yasuyuki Ohta, Toru Yamashita, Nozomi Hishikawa, Kota Sato, Kosuke Matsuzono, Keiichiro Tsunoda, Noriko Hatanaka, Mami Takemoto, Toshihiko Takemi, Kazuhiro Takamatsu, Koji Abe |
Journal | Journal of the neurological sciences
(J Neurol Sci)
Vol. 373
Pg. 216-222
(Feb 15 2017)
ISSN: 1878-5883 [Electronic] Netherlands |
PMID | 28131191
(Publication Type: Comparative Study, Journal Article)
|
Copyright | Copyright © 2017 Elsevier B.V. All rights reserved. |
Chemical References |
- Radiopharmaceuticals
- Tropanes
- 2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane
- 3-Iodobenzylguanidine
|
Topics |
- 3-Iodobenzylguanidine
- Aged
- Brain
(diagnostic imaging)
- Family
- Female
- Humans
- Magnetic Resonance Imaging
- Male
- Middle Aged
- Myocardial Perfusion Imaging
- Parkinson Disease
(diagnostic imaging, physiopathology)
- Pedigree
- Radiopharmaceuticals
- Spinocerebellar Degenerations
(diagnostic imaging, physiopathology)
- Supranuclear Palsy, Progressive
(diagnostic imaging, physiopathology)
- Tomography, Emission-Computed, Single-Photon
- Tropanes
|